ATE529133T1 - Topisches präparat - Google Patents

Topisches präparat

Info

Publication number
ATE529133T1
ATE529133T1 AT05768591T AT05768591T ATE529133T1 AT E529133 T1 ATE529133 T1 AT E529133T1 AT 05768591 T AT05768591 T AT 05768591T AT 05768591 T AT05768591 T AT 05768591T AT E529133 T1 ATE529133 T1 AT E529133T1
Authority
AT
Austria
Prior art keywords
present
mast cell
cell degranulation
degranulation inhibitor
preparation containing
Prior art date
Application number
AT05768591T
Other languages
English (en)
Inventor
Mitsuru Endo
Keiko Yamasaki
Hidetoshi Hamamoto
Sueko Matsumura
Masaki Ishibashi
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Application granted granted Critical
Publication of ATE529133T1 publication Critical patent/ATE529133T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05768591T 2004-08-18 2005-08-01 Topisches präparat ATE529133T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004238167 2004-08-18
JP2005021549 2005-01-28
PCT/JP2005/014468 WO2006018997A1 (ja) 2004-08-18 2005-08-01 外用剤

Publications (1)

Publication Number Publication Date
ATE529133T1 true ATE529133T1 (de) 2011-11-15

Family

ID=35907387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05768591T ATE529133T1 (de) 2004-08-18 2005-08-01 Topisches präparat

Country Status (5)

Country Link
US (1) US7592371B2 (de)
EP (1) EP1782831B1 (de)
JP (1) JP4843824B2 (de)
AT (1) ATE529133T1 (de)
WO (1) WO2006018997A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264664A1 (en) * 2005-10-21 2009-10-22 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
JP2008031079A (ja) * 2006-07-28 2008-02-14 Sigma Soyaku Kk 花粉症に伴う症状を抑えるための薬剤
WO2008093686A1 (ja) * 2007-01-29 2008-08-07 Medrx Co., Ltd. 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途
JP5670008B2 (ja) * 2007-01-31 2015-02-18 大正製薬株式会社 アダパレン含有外用剤組成物
EP2311498A4 (de) * 2008-08-05 2013-07-24 Medrx Co Ltd Externes präparat mit einem fettsäuresalz oder einem benzoesäuresalz aus einer basischen pharmakologischen wirkstoffkomponente sowie verfahren zu seiner herstellung
AU2013239114B2 (en) * 2012-03-30 2017-07-20 Nuformix Limited Tranilast compositions and cocrystals
AU2015258472B2 (en) * 2014-05-15 2020-05-21 Grunenthal Gmbh Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ
PL3273952T3 (pl) 2015-03-26 2022-11-14 SEN-JAM Pharmaceutical LLC Kombinacja naproksenu i feksofenadyny w celu zahamowania objawów związanych z zatruciem alkoholem

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
JPH06128153A (ja) * 1992-10-16 1994-05-10 Kissei Pharmaceut Co Ltd トラニラスト軟膏組成物およびその製造方法
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
DE974350T1 (de) 1996-02-07 2001-01-25 Kissei Pharmaceutical Co., Ltd. Tranilast enthaltendes externum und verfahren zu dessen herstellung
US6429228B1 (en) * 1996-10-14 2002-08-06 Kowa Company, Ltd. Local anesthetic for external use
US20010004644A1 (en) 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
KR20010022041A (ko) * 1997-07-21 2001-03-15 클래스 빌헬름슨 뇌 신경혈관 장애 및 근육성 두통 억제용 조성물, 키트 및방법
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
JP4295841B2 (ja) 1998-05-11 2009-07-15 アピ株式会社 抗アレルギー外用剤
JP4684404B2 (ja) 2000-10-26 2011-05-18 第一三共株式会社 消炎鎮痛外用剤組成物
US6468557B1 (en) * 2001-01-05 2002-10-22 Alphamed Pharmaceutical Corp. Method for treating infectious viral diseases
JP4106232B2 (ja) * 2001-05-09 2008-06-25 ロート製薬株式会社 医薬組成物
JP4176358B2 (ja) 2002-03-01 2008-11-05 天藤製薬株式会社 痔疾用医薬組成物
AU2003256284A1 (en) * 2002-06-20 2004-01-06 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
ES2397574T3 (es) * 2002-07-30 2013-03-08 Omeros Corporation Procedimiento y soluciones de irrigación oftalmológica
US7166641B2 (en) 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
JP2004161625A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状皮膚疾患治療用外用剤

Also Published As

Publication number Publication date
JPWO2006018997A1 (ja) 2008-05-08
JP4843824B2 (ja) 2011-12-21
EP1782831B1 (de) 2011-10-19
US7592371B2 (en) 2009-09-22
EP1782831A1 (de) 2007-05-09
EP1782831A4 (de) 2009-12-02
WO2006018997A1 (ja) 2006-02-23
US20080108700A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
CO5590929A2 (es) Derivados de acetileno que tienen actividad antagonica de mgiur5
NO20080068L (no) Topisk unguale formuleringer
UY27729A1 (es) Inhibidores de quinasas.
DE602005026508D1 (de) Monozyklische heterozyklen als kinase-hemmer
ATE479013T1 (de) Integriertes magnetisches vermessungswerkzeug
BRPI0511621A (pt) compostos orgánicos
CL2009000782A1 (es) Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades.
NO20071127L (no) Triazoloftalaziner
NO20082298L (no) Kaliumkanalinhibitorer
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
AR029696A1 (es) Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra
ATE529133T1 (de) Topisches präparat
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
CR7717A (es) Nuevos inhibidores biciclicos de hormona sensitiva a la lipasa
EA200801607A1 (ru) Производные бензимидазолонкарбоновой кислоты
CR9472A (es) Derivados de aminoacidos
ATE465159T1 (de) (s)-(-)-1-(4-fluorisochinolin-5-yl)sulfonyl-2- methyl-1,4-homopiperazinhydrochlorid- dihydrat
CO5700779A2 (es) Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
BRPI0509926A (pt) imidazóis
ATE512967T1 (de) Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen
NO20091771L (no) Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat
DE602004011946D1 (de) Alkalisalze von protonenpumpen-hemmern
ATE480542T1 (de) Pyrroloä1,2-düä1,2-4ütriazin als inhibitoren von c-jun-n-terminal-kinasen (jnk) und p-38-kinasen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties